BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the following segments: BioProducts, BioScience, and BioIncubator. The BioProducts segment consists of the product business with enzymes and other proteins. The BioScience segment offers research-intensive and customized solutions. The BioIncubator segment includes promising research and development projects with high value-added potential. The company was founded by Holger Zinke, Jüngen Eck, and Hans Günter Gassen on September 22, 1993 and is headquartered in Zwingenberg, Germany.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company